What is the official ID of this bill?
The official print number for this legislation is HR 2408.
Easier Access to Innovative Drugs in Medicare Program
This bill introduces a new appeal process for Medicare decisions that deny or limit access to approved drugs. Citizens will have the opportunity to comment on these decisions, which may accelerate access to new therapies and ensure greater transparency in the drug approval process.
Key points
Establishes a review process for Medicare decisions denying coverage for approved drugs.
Introduces a 30-day public comment period for drug coverage determinations.
Prohibits applying old Medicare decisions to newly approved drugs if it limits access.
Ensures prescription drug plans cannot deny coverage based on outdated determinations.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.